New nasal vaccines may be given together
Key points
- Two new nasally administered vaccines for respiratory infections are being tested, and researchers now say that giving them together to young children appears feasible.
- Respiratory syncytial virus (RSV) and parainfluenza virus 3 (PIV3) are important causes of serious respiratory tract diseases in infants and toddlers, according to a report in the Journal of Infectious Diseases.
- Belshe from Saint Louis University, Missouri, and colleagues evaluated intra-nasal RSV and PIV3 vaccines given either simultaneously or separately in an early-stage study involving 54 healthy children between 6 and 18 months old.
- Both the RSV and the PIV3 vaccines induced immunity, the investigators report, and the frequency of protective antibody responses for RSV and PIV3 did not differ significantly between the separate and simultaneous vaccine groups.
Two new nasally administered vaccines for respiratory infections are being tested, and researchers now say that giving them together to young children appears feasible.
Respiratory syncytial virus (RSV) and parainfluenza virus 3 (PIV3) are important causes of serious respiratory tract diseases in infants and toddlers, according to a report in the Journal of Infectious Diseases.
Dr. Robert B. Belshe from Saint Louis University, Missouri, and colleagues evaluated intra-nasal RSV and PIV3 vaccines given either simultaneously or separately in an early-stage study involving 54 healthy children between 6 and 18 months old.
Both the RSV and the PIV3 vaccines induced immunity, the investigators report, and the frequency of protective antibody responses for RSV and PIV3 did not differ significantly between the separate and simultaneous vaccine groups.
None of the children developed a respiratory infection resulting from vaccination, the researchers note, and all vaccine recipients showed a similar pattern of illnesses to that seen in placebo recipients.
"The results of the present test-of-concept trial provide the framework for future development of bivalent RSV/PIV3 vaccine," the team concludes.
SOURCE: Journal of Infectious Diseases, December 15, 2004.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →News740,000 vaccines urgently needed to control outbreak of Japanese encephalitis
According to official sources Japanese encephalitis has to date claimed 19 lives in the northern Chinese city of Yuncheng in the Shanxi province. Local health authorities say 740,000 vaccines are urgently needed to…
15 August 2006
NewsBerlin station stab victims given HIV prevention
Twenty-eight people stabbed on a crowded street by a drunken German teenager are receiving protective treatment for the next four weeks after it emerged that one victim was HIV positive, authorities said on Sunday. A…
30 May 2006
NewsNew technology for accelerating development of vaccines against H5N1 flu
Technology that enables scientists to identify targets for the development of vaccines against viruses such as H5N1 in weeks rather than months has entered a pilot study at ProImmune, Oxford, UK. ProImmune has developed…
